NutriStack
Search the library Supplements Prescriptions Interactions Goals Symptoms Methodology
← Back to NutriStack

Oseltamivir

Prescription ·Moderate evidence ·Reviewed May 2026

A neuraminidase inhibitor antiviral used for the treatment and prevention of influenza A and B. Most effective when started within 48 hours of symptom onset, reducing symptom duration by approximately 1-2 days and potentially reducing complications (pneumonia, hospitalization). Recommended by the CDC for high-risk patients with influenza, including the elderly, immunocompromised, pregnant women, and those with chronic medical conditions.

Evidence tier
Moderate
Indexed sources
10 2015–2025
Interactions
5
Category
Prescription
Read the sources → Compare profiles
What it's good for
  • Reduces influenza symptom duration by 1-2 days1,2
  • Reduces risk of influenza-associated complications1,2
  • Post-exposure prophylaxis for influenza contacts1,2
  • Seasonal prophylaxis in high-risk populations8
  • Active against both influenza A and B1,2
What to watch for
  • Nausea and vomiting (most common)
  • Headache
  • Diarrhea
  • Known hypersensitivity to oseltamivir or any component1,2
  • Not a substitute for annual influenza vaccination1,2

The bottom line

Evidence rating moderate. Most-documented uses: reduces influenza symptom duration by 1-2 days, reduces risk of influenza-associated complications, post-exposure prophylaxis for influenza contacts. 10 sources indexed (2015–2025), with 5 interaction records on file.

The science

How it works, mechanistically.

Core mechanism

A prodrug (ethyl ester) that is hydrolyzed by hepatic esterases to the active carboxylate form, oseltamivir carboxylate. The active metabolite competitively inhibits neuraminidase (sialidase), a glycoprotein enzyme on the surface of influenza A and B virions. Neuraminidase cleaves sialic acid residues on the host cell surface, which is essential for the release of newly formed virions from infected cells, spread to uninfected cells, and penetration of respiratory mucus. Inhibition results in viral aggregation on the cell surface and impaired spread.

Class
Neuraminidase Inhibitor Antiviral
Absorption
Water-soluble; take with food
Dosing

Dosing & protocol.

Common range
Treatment: 75 mg BID x 5 days (start within 48 hours of symptom onset); prophylaxis: 75 mg once daily x 10 days; pediatric dosing weight-based (as prescribed by your physician)
Recommended form
Oral capsules or oral suspension

Prodrug is well absorbed with approximately 80% bioavailability (as active carboxylate). Food does not reduce bioavailability but may reduce nausea. Can be taken with or without food.

Safety

Full safety detail.

Side effects

  • Nausea and vomiting (most common)
  • Headache
  • Diarrhea
  • Abdominal pain
  • Neuropsychiatric events (rare, delirium, hallucinations, abnormal behavior, primarily reported in pediatric patients in Japan)

Contraindications

  • Known hypersensitivity to oseltamivir or any component1,2
  • Not a substitute for annual influenza vaccination1,2
  • Severe renal impairment (CrCl <30 mL/min) requires dose adjustment
Interactions

Interaction records.

InfoSynergy

Elderberry

Elderberry (Sambucus nigra) flavonoids inhibit influenza H1N1 attachment in vitro and small randomized trials suggest modest reductions in influenza duration and severity. A 2021 systematic review found no evidence of immune over-stimulation or cytokine storm risk, and there is no known pharmacokinetic interaction with oseltamivir, making the combination a reasonable adjunct during acute influenza.

Recommendation: Standardized elderberry extract (e.g., 175-300 mg/day or label dose) may be used alongside oseltamivir for acute influenza in healthy adults. Start within 48 hours of symptom onset; do not use elderberry instead of oseltamivir.

InfoSynergy

Elderberry Zinc Lozenges

Elderberry blocks influenza H1N1 attachment in vitro and zinc lozenges (acetate or gluconate) reduce common cold duration in meta-analyses. Combined with oseltamivir, which inhibits viral neuraminidase, the mechanisms are non-overlapping. The combination is low risk for short courses but high-dose zinc (>40 mg elemental/day) chronically causes copper deficiency.

Recommendation: Elderberry zinc lozenges are a reasonable adjunct during acute influenza alongside oseltamivir. Limit to the labeled course (typically less than 2 weeks) to avoid copper depletion. Do not exceed 75-100 mg elemental zinc daily acutely.

InfoSynergy

Echinacea

Echinacea purpurea preparations have demonstrated in vitro activity against influenza viruses and a randomized comparative trial of Echinaforce hot drink versus oseltamivir suggested similar early symptom improvement with fewer adverse events. While Echinacea is not a replacement for neuraminidase inhibitors, combination use as an adjunct is biologically plausible and low risk in immunocompetent adults.

Recommendation: Echinacea may be used as an optional adjunct to oseltamivir for influenza in healthy adults, started early in illness. Avoid Echinacea if you are on immunosuppressants (e.g., methotrexate, transplant medications) or have an autoimmune disease.

InfoSynergy

Zinc

Zinc supports antiviral immune function and meta-analyses show modest reductions in common cold duration with zinc lozenges. While direct trials of zinc plus oseltamivir for influenza are lacking, the mechanisms are non-overlapping and the combination is low risk for short-term use during acute illness.

Recommendation: Modest oral zinc (15-25 mg/day with food) or zinc lozenges per label for the duration of acute influenza are reasonable alongside oseltamivir. Avoid chronic high-dose zinc, which can cause copper deficiency.

InfoSynergy

Vitamin D3

Vitamin D supplementation modestly reduces the risk of acute respiratory infections, particularly in deficient individuals, per a large individual participant data meta-analysis. While direct combination trials with oseltamivir are absent, maintaining adequate vitamin D status supports antiviral immune function and is a reasonable background measure during influenza treatment.

Recommendation: If your vitamin D level is low or unknown, maintaining 1000-2000 IU/day vitamin D3 is reasonable alongside oseltamivir during influenza season. Do not use vitamin D as treatment for active influenza in lieu of oseltamivir.

Search all 5 interaction records for Oseltamivir →

Sources

Sources, by evidence tier.

Numbered references. Citations throughout the page link here.

Meta-analyses & systematic reviews

5

Reference material

5
Keep exploring

Deep dives & adjacent profiles.

ValacyclovirPrescriptionTrimethoprim-SulfamethoxazolePrescriptionTiotropiumPrescriptionPseudoephedrinePrescriptionNitrofurantoinPrescriptionMontelukastPrescription

This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.

Use this with your stack

Oseltamivir in NutriStack.

Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.

Download on the App Store → Read the methodology

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.